J. Infect. Dis.
204, 1349–57.
LPLUNC1 modulates innate immune responses to Vibrio cholerae.
2011
Shin, O.S., Uddin, T., Citorik, R., Wang, J.P., Della Pelle, P., Kradin, R.L., Bingle C.D., Bingle, L., Camilli, A., Bhuiyan, T.R., Shirin, T., Ryan, E.T., Calderwood, S.B., Finberg, R.W., Qadri, F., Larocque, R.C. and Harris, J.B.
Notes: The authors used the Dual-Glo™ Luciferase Assay system to detect induction of NF-κB activity in transfected HEK-TLR4/MD2 cells expressing human CD14, toll-like receptor 4 (TLR4) and MD2. An NF-κB-driven luciferase reporter gene and a thymidine kinase (TK) promoter-driven Renilla luciferase reporter gene were measured 24 hours after the cells were exposed to long palate, lung, and nasal epithelium clone 1 protein (LPLUNC1) 1 hour prior to stimulation with lipopolysaccharide (LPS) from either E. coli or V. cholera. Figure 4 shows how LPLUNC1 was able to inhibit the TLR4 response to LPS from V. cholera. It was hypothesized that LPLUNC1 serves to reduce inflammation to enteric pathogens. Transfection details: Cells were seeded in 96-well plates at 30,000 cells/well and transfected with a total of 0.3µg of DNA per well. The transfected DNA contained 80ng of NF-κB-firefly luciferase plasmid and 20ng HSV-TK promoter-driven Renilla luciferase plasmid, along with human CD14 construct cloned into pCDNA3 at 10ng/well. (4177)
Expand Full Notes »